Devon, PA (GLOBE NEWSWIRE) – Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare and near-rare neurological and psychiatric disorders with high unmet medical needs, today announced that it has initiated the Phase 2 BELIEVE 1 (Open Label Study to Assess the […]

by

When Peru’s medical marijuana law was signed by President Pedro Pablo Kuczynski on Nov. 16, it was hailed as a victory by advocates — especially the mothers of the Buscando Esperanza (Seeking Hope) collective, who were producing cannabis for their ailing children. The police raid on their operation in a Lima apartment just over a year ago […]

by

Cosmetics and natural medicines company Bod Australia (ASX: BDA) has added yet another string to its commercial bow, by completing its first order for medicinal cannabis oil from Swiss company Linnea Natural Pharma Solutions. Having already obtained approval from Australian regulators in February, the completed order means Bod can now set about commercialising this additional […]

by

ADVISORY, April 10, 2018 (GLOBE NEWSWIRE) — What: Intec Pharma Ltd. (Nasdaq:NTEC), a biopharmaceutical company developing a treatment for Parkinson’s disease symptoms in advanced Parkinson’s disease patients, will visit the Nasdaq MarketSite in Times Square in observance of World Parkinson’s Day. In honor of the occasion, Jeffrey A. Meckler, Chief Executive Officer and Vice Chairman of […]

by

DEVON, Pa., April 10, 2018 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare and near-rare neurological and psychiatric disorders with high unmet medical needs, today announced that it has initiated the Phase 2 BELIEVE 1 (Open Label Study […]

by

As more states legalize both medical and recreational marijuana, products containing extracts from the plant are appearing on shelves around the country too. Cannabidiol, commonly abbreviated as CBD, is one such compound that’s now available in various formulations at smoke shops, health food stores and dispensaries. Though CBD is extracted from cannabis, unlike another cannabinoid, […]

by

DEVON, Pa., April 10, 2018 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare and near-rare neurological and psychiatric disorders with high unmet medical needs, today announced that it has initiated the Phase 2 BELIEVE 1 (Open Label Study […]

by

All the way back in 2003 CSL Limited (ASX: CSL) shares were changing hands at under $12.00. Fifteen years later those same shares have increased in value by over 1,200% and recently traded as high as $159.62. While only time will tell whether the biotech shares listed below can have similar success, I think they […]

by

Twelve new game-changing drugs are predicted to achieve blockbuster status by 2022, according to the newly released 2018 edition of Drugs to Watch, the annual industry forecast and analysis from Clarivate Analytics. More blockbusters — drugs projected to achieve $1 billion in sales within five years — have been predicted to launch in 2018 than […]

Ann Marie Owen walks with her husband, Bruce, near their home in Port Ewen, N.Y. Owen says the opioids prescribed by doctors made her feel sick and failed to ease her pain. Medical marijuana, she says, saved her life. Allyse Pulliam for Kaiser Health News hide caption … read more at: https://www.npr.org/sections/health-shots/2018/04/07/600209754/medical-marijuanas-catch-22-limits-on-research-hinders-patient-relief

Ann Marie Owen walks with her husband, Bruce, near their home in Port Ewen, N.Y. Owen says the opioids prescribed by doctors made her feel sick and failed to ease her pain. Medical marijuana, she says, saved her life. Allyse Pulliam for Kaiser Health News hide caption … read more at: https://www.npr.org/sections/health-shots/2018/04/07/600209754/medical-marijuanas-catch-22-limits-on-research-hinders-patient-relief